IPP Bureau

Merck FY20 sales up 8.6% euro 17.5 bn
Merck FY20 sales up 8.6% euro 17.5 bn

By IPP Bureau - March 04, 2021

Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.

DSM increases price for polyamide 6 and 66 in EMEA
DSM increases price for polyamide 6 and 66 in EMEA

By IPP Bureau - March 02, 2021

The price increases are due to the rising costs of raw materials.

DSM secures victory in patent infringement litigation against Anhui Tiger
DSM secures victory in patent infringement litigation against Anhui Tiger

By IPP Bureau - March 02, 2021

Tiger can no longer make an important biotin intermediate using a DSM patented process.

Piramal Enterprises cashing in on opportunities: ICICI Securities
Piramal Enterprises cashing in on opportunities: ICICI Securities

By IPP Bureau - March 02, 2021

PEL will explore the PLI scheme and apply if its beneficial.

Bayer delivers robust performance despite pandemic
Bayer delivers robust performance despite pandemic

By IPP Bureau - February 26, 2021

The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.

India approves PLI scheme for pharmaceuticals
India approves PLI scheme for pharmaceuticals

By IPP Bureau - February 26, 2021

Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.

Government allocates over Rs. 10,000 Cr in PLI scheme for bulk drugs and medical devices: Gowda
Government allocates over Rs. 10,000 Cr in PLI scheme for bulk drugs and medical devices: Gowda

By IPP Bureau - February 26, 2021

The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.

Granules India gets USFDA approval of acetaminophen, aspirin and caffeine tablets
Granules India gets USFDA approval of acetaminophen, aspirin and caffeine tablets

By IPP Bureau - February 25, 2021

ranules now has a total of 38 ANDA approvals from US FDA.

Aurobindo Pharma to acquire 26% ownerships solar power companies
Aurobindo Pharma to acquire 26% ownerships solar power companies

By IPP Bureau - February 24, 2021

The company will be holding 26% of the share capital in each of the solar power generating companies.

USFDA denies Sun Pharma Advanced Research’s appeal of NDA for Taclantis
USFDA denies Sun Pharma Advanced Research’s appeal of NDA for Taclantis

By IPP Bureau - February 24, 2021

The company will review FDA's response and decide on appropriate next steps soon.

Thermo Fisher’s new facility in Bengaluru to produce reliable COVID-19 testing kits
Thermo Fisher’s new facility in Bengaluru to produce reliable COVID-19 testing kits

By IPP Bureau - February 23, 2021

Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by ICMR and DCGI.

“Minus 20°C is sometimes trickier than minus 70°C”
“Minus 20°C is sometimes trickier than minus 70°C”

By IPP Bureau - February 22, 2021

DHL and other logistics companies were already transporting pharmaceutical products at minus 70°C in Schaumaplast boxes packed with dry ice before the coronavirus pandemic

Unichem Laboratories receives ANDA approval for Apremilast Tablets
Unichem Laboratories receives ANDA approval for Apremilast Tablets

By IPP Bureau - February 20, 2021

Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .

Zydus Cadila receives final approval from USFDA for Droxidopa capsules
Zydus Cadila receives final approval from USFDA for Droxidopa capsules

By IPP Bureau - February 20, 2021

It is used to treat low blood pressure that causes severe dizziness or a lightheaded feeling.

Lupin receives approval for Droxidopa capsules
Lupin receives approval for Droxidopa capsules

By IPP Bureau - February 20, 2021

Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness

Latest Stories

Interviews

Packaging